Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
University of California, Irvine · NCT00842283
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 16+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 85
- US sites recruiting
- 2
- Study start
- November 2008
- Record last updated
- April 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The researchers believe that pro-angiogenic factors are upregulated in a wide range of dermatologic diseases, including port wine stains, hemangiomas, angiofibromas, Kaposi's sarcoma, angiosarcoma, scars, rosacea, and psoriasis. Select specimens may undergo genetic analysis to investigate underlying molecular pathways associated with dysregulated angiogenesis in cutaneous disease.
Biospecimens, either previously obtained or newly collected from dermatologic conditions, will be analyzed for angiogenic markers. Discarded skin tissue from surgical or biopsy procedures may also be used, including both diseased and non-diseased tissue from the same donor. Some specimens may also undergo genetic analysis to investigate underlying molecular pathways.
De-identified data such as age, sex, race, cause of death, lesion location, and description will be recorded. Currently, specimens are limited to clinically diagnosed lesions not typically biopsied, or lesions already confirmed by prior biopsy.
Being studied: skin tissue sample
Conditions: Dermatologic Diseases
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 16 years of age or older.
- willing to have a skin biopsy
Exclusion Criteria
- under 16 years of age
- unable to carry out instructions
Recruiting US locations
Beckman Laser Institute and Medical Clinic
Irvine, CA 92697
Site contact: Hanna Kim · 949-824-2251 · hhkim3@uci.edu
Dermatology Clinic at Gavin Herbert Eye Institute
Irvine, CA 92697
Site contact: Hanna Kim · 949-824-2251 · hhkim3@uci.edu
Study contacts (from the official record)
- Hanna Kim · 949-824-2251 · hhkim3@uci.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55